Efficacy and safety of the interleukin-1 antagonist rilonacept in Schnitzler syndrome: an open-label study
Allergy, 06/15/2012
Krause K et al. – Rilonacept was effective and well tolerated in patients with Schnitzler syndrome (SchS) and may represent a promising potential therapeutic option.



